Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Building Materials

Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.

Revenue projections:

Revenue projections for AMBUJACEM
Revenue projections for AMBUJACEM

Ambuja Cements Limited's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.

Financial Ratios:

currentRatio 0.000000
forwardPE 28.660427
debtToEquity 1.829000
earningsGrowth -0.905000
revenueGrowth 0.102000
grossMargins 0.572630
operatingMargins 0.038340
trailingEps 14.970000
forwardEps 15.490000

AMBUJACEM's Forward PE is in a reasonable range, indicating the stock is priced well relative to its earnings. The stock isn't overpriced, which leaves room for future growth, making it an attractive option for investors seeking value and long-term gains.
Ambuja Cements Limited's low earnings and revenue growth suggest shrinking profits. This negative trend could indicate that the company is struggling to maintain its financial performance and may face challenges ahead.
AMBUJACEM's negative gross and operating margins indicate that the company is unable to generate profit from its core business activities. This suggests financial strain and could be a sign of deeper cost management issues.
AMBUJACEM's forward EPS being higher than its trailing EPS signals anticipated growth in profitability for the current financial year. This suggests that AMBUJACEM is on track to improve its earnings, outpacing the previous year's performance and reflecting positive market expectations.

Price projections:

Price projections for AMBUJACEM
Price projections for AMBUJACEM

Price projections for AMBUJACEM have been gradually lowered, signaling reduced optimism among analysts. This downward adjustment suggests that the company may face challenges in meeting previous growth expectations.

Recommendation changes over time:

Recommendations trend for AMBUJACEM
Recommendations trend for AMBUJACEM


Analysts' buy bias toward AMBUJACEM suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, AMBUJACEM is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.